ResearcherLanzhou University Second HospitalActive in the last 2 years

Zhijian Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6046-4072; OpenAlex author ID A5034989697. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper

Papers 1

Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment. Co-author DOI 10.1111/cas.16059 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yiwei Dai · 1 shared paper, 2024 · strength 0.26
- Paper Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment. DOI 10.1111/cas.16059 ↗
Zuoyi Jiao · 1 shared paper, 2024 · strength 0.26
- Paper Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment. DOI 10.1111/cas.16059 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.